Nuclear Medicine Equipment Market Worth 2.13 Billion USD by 2020

Sep 11, 2015, 09:30 ET from MarketsandMarkets

PUNE, India, September 11, 2015 /PRNewswire/ --

According to a new market research report "Nuclear Medicine Equipment Market by Product (SPECT (Hybrid SPECT, Standalone SPECT), hybrid PET, & Planar Scintigraphy), by Application (Cardiology, Oncology & Neurology), by End user (Hospitals, Imaging Centers) - Global Forecasts to 2020", published by MarketsandMarkets, this report studies the global Nuclear Medicine Equipment Market for the forecast period of 2015 to 2020. This market is expected to reach USD 2.13 Billion by 2020 from USD 1.78 Billion in 2015, and is poised to grow at a CAGR of 3.6% during the forecast period.

Browse 83 Tables and 42 Figures spread through 161 Pages and in-depth TOC on "Nuclear Medicine Equipment"

Early buyers will receive 10% customization on this report. 

The global Nuclear Medicine Equipment Market is segmented on the basis of product, application, end user, and region.

Based on product, the Nuclear Medicine Equipment Market is categorized into hybrid PET, SPECT, and planar scintigraphy systems. The SPECT product segment is further divided into hybrid SPECT and standalone SPECT.  In 2015, SPECT products segment is estimated to account for a major share of the Nuclear Medicine Equipment Market.

Based on application, the market is segmented into oncology, cardiology, neurology and other applications which includes orthopedics, urology, thyroid related disorders, and gastroenterology. In 2015, the cardiology segment is estimated to account for a major share of the Nuclear Medicine Equipment Market.

Ask For PDF Brochure:

On the basis of end user, the market is classified into hospitals, imaging centers, academic and research institutes and others which include pharma/biotech companies and CROs. In 2015, hospitals segment is estimated to account for a major share of the Nuclear Medicine Equipment Market.

On the basis of region, the market is divided into North America, Europe, Asia-Pacific, and the Rest of the World (RoW). In 2015, North America accounted for the largest share of the Nuclear Medicine Equipment Market, followed by Europe and Asia-Pacific. However, the Asia-Pacific market is slated to grow at the highest CAGR during the forecast period and serve as a revenue pocket for the companies offering nuclear medicine equipment.

Over the years, the Nuclear Medicine Equipment Market has witnessed various new products being launched coupled with the various technological advancements. These advancements have led to the nuclear medicine procedures more effectively. Incessant introduction of new and advanced products, investment in modernisation of diagnostic imaging centers, development of new radiotracers, and rising incidence and prevalence of cancer and cardiovascular diseases are the key factors driving the growth of the global Nuclear Medicine Equipment Market. Additionally, factors such as increasing prevalence of diseases associated with aging population, strong product pipeline, and growing demand for nuclear medicine procedures in the emerging market are also expected to fuel market growth in the coming years.

On the other hand, high cost of nuclear medicine equipment, decreasing reimbursements for radiology, and unfavourable healthcare reforms in the U.S. are key factors limiting the growth of this market. In addition to this, hospital budget constraints and increasing adoption of refurbished systems are major challenges faced by industry players in the global Nuclear Medicine Equipment Market.

Some of the major players in the global Nuclear Medicine Equipment Market include Philips Healthcare (Netherlands), GE Healthcare (U.K.), Siemens Healthcare (Germany), Digirad Corporation (U.S.), Mediso Medical Imaging Systems, Ltd. (Hungary), Toshiba Medical Systems Corporation (Japan), DDD-Diagnostics A/S (Denmark), Neusoft Medical Systems Co. Ltd. (China), SurgicEye GmbH (Germany), and CMR Naviscan Corporation (U.S.)

Browse Related Reports: 

Nuclear Medicine/Radiopharmaceuticals Market by Type (Diagnostic (SPECT - Technetium, PET - F-18), Therapeutic (Beta Emitters - I-131, Alpha Emitters, Brachytherapy - Y-90) & by Application (Oncology, Thyroid, Cardiology) - Global Forecasts to 2020.

Diagnostic Imaging Market by X-ray Systems (Digital, Analog, Portable), Computed Tomography, Ultrasound Imaging Systems (2D, 3D, 4D, Doppler), MRI Machines (Closed & Open), and Nuclear Imaging Systems (SPECT, PET, PET/CT) - Global Forecasts to 2018.

About MarketsandMarkets: 

MarketsandMarkets is world's No. 2 firm in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model - GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors.

M&M's flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. The new included chapters on Methodology and Benchmarking presented with high quality analytical infographics in our reports gives complete visibility of how the numbers have been arrived and defend the accuracy of the numbers.

We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.

Mr. Rohan
Unit No. 802, 8th Floor, 
Tower - 7, Magarpatta City SEZ,
Hadapsar, Pune - 411013, 
Maharashtra, India.
Tel: +1-888-6006-441.
Visit MarketsandMarkets Blog @
Connect with us on LinkedIn @

SOURCE MarketsandMarkets